Clinical trial
Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia. Randomized Open-label Clinical Trial
NCT05899842 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia. Randomized Open-label Clinical Trial
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 1, 2023
- Completion date
- February 29, 2028
- Enrollment
- 132 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.